NITRO: A randomised phase 3 trial of adding nitroglycerin to first line chemotherapy for advanced non-small cell lung cancer [ 2014 - 2016 ]

Research Grant

Researchers: A/Pr Andrew Davidson (Principal investigator) ,  A/Pr Brett Hughes ,  A/Pr Paul Mitchell ,  A/Pr Sue-Anne Mclachlan ,  Prof Michael Boyer
View all 6 related researchers

Brief description Preliminary studies suggest that nitroglycerin paste can substantially improve the results of chemotherapy for advanced lung cancer. NITRO is a definitive, large-scale, randomised trial that is needed to reliably determine if these promising results are true, and worthy of widespread application in routine clinical practice.

Funding Amount $AUD 504,960.41

Funding Scheme Project Grants

Notes Standard Project Grant